Andrew Abba Stolz

Andrew Abba Stolz, MD is a Professor of Medicine at the University of Southern California and serves as Associate Chair for Faculty Affairs for the Department of Medicine, as well as Chair of the Faculty Appointments and Promotion Tenure Committee (FAPTC Panel B). He has been a key member of the Division of Gastrointestinal and Liver Diseases since 1990, earning tenure shortly after joining the institution.

Dr. Stolz's research focuses on liver disease mechanisms, particularly protein-mediated intracellular transport of bile acids in the liver, molecular characterization of Aldo-Keto Reductase supergene family members across species, dysregulation of hormone catabolism in human breast and prostate cancers, and drug-induced liver injury. His work spans molecular biology, clinical hepatology, and pharmacogenetics, with particular emphasis on understanding the mechanisms of liver injury from various pharmaceutical and dietary compounds.

His recent publications demonstrate a strong focus on drug-induced liver injury, with particular attention to genetic and immunological factors that contribute to susceptibility. His research employs advanced methodologies including proteomics, transcriptomics, and machine learning approaches to identify biomarkers and improve diagnostic capabilities for various liver conditions.

• 17th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology: Fabre Laboratories Best Poster, 2006
• American Liver Foundation: Postdoctoral Fellowship, 1983-1985

Dr. Stolz earned his medical degree at Albert Einstein College of Medicine, completed his residency at Mt. Sinai Hospital, and performed a Gastroenterology Fellowship at UCLA. His extensive publication record spanning several decades demonstrates sustained contributions to the field of hepatology and drug safety research.